Autres langues

11/09 Relmada Therapeutics Shares Rise After CEO, CFO Buy 200,000 Shares Each
08/09 Relmada Therapeutics, Inc. Announces Resignation of Raj S. Pruthi as Chief Medical Officer Urology, Effective September 3, 2026
01/09 Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference
07/08 Relmada Therapeutics : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
06/08 Relmada Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
06/08 Relmada Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update
28/07 Relmada Therapeutics, Inc. Announces Appointment of Bipin Dalmia as Chief Business Officer
28/07 Relmada Therapeutics Appoints Uro-Oncology Leader Bipin Dalmia as Chief Business Officer
16/07 Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Small Cap Comp Growth Benchmark
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 2500 Growth Benchmark
29/06 Relmada Therapeutics Joins Russell 2000, Russell 3000 Indexes
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 2000 Index
29/06 Relmada Therapeutics Joins Russell 2000® and Russell 3000® Indexes
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 2000 Growth Benchmark
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 3000E Index
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Microcap Index
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 3000E Growth Benchmark
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 2000 Dynamic Index
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Microcap Growth Benchmark Index
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell Small Cap Completeness Index
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 3000 Growth Benchmark
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 2500 Index
29/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to Russell 3000 Index
22/06 Relmada Therapeutics, Inc.(NasdaqCM:RLMD) added to S&P Pharmaceuticals Select Industry Index
Aucun résultat pour cette recherche
DERNIÈRES HEURES | -40% : Les Meilleurs Outils Réservés aux Abonnés pour Identifier les Meilleurs Investissements de Demain !
j
:
:
PROFITEZ-EN MAINTENANT